Every year during the holidays, the SVA team stops to reflect on the joy and blessings in their lives, while also being aware...

In a rapid launch, the process behind getting started can often be intimidating and lead to chaos and confusion. Simplify it...

SVA Life Sciences, a division of SVA Consulting, is featured in the November 2022 edition of Pharma Tech Outlook magazine. In the...

Across the life sciences industry, many struggle to demonstrate the value of Medical Affairs. We’ve talked about why it’s...

SVA Life Sciences’ Principals Andrew DeMarco and Jenny Herritz, along with Ryan Irvine, Vice President of Medical Affairs at...

SVA Life Sciences is proud to announce the firm will be an exhibitor at the 2022 World Orphan Drug Congress held on July 11-13,...

SVA Life Sciences, a division of SVA Consulting, is pleased to announce that Sara’s Cure (DBA Clear Cell Sarcoma Foundation) has...

Andrew DeMarco, SVA Life Sciences Principal and Commercialization Strategist, and Chuck Howe, member of the SVA Life Sciences...

Why Organizational Readiness Should be Priority of First-Time Launchers You’ve done groundbreaking research, developed options,...

Your biopharma company is evolving. You have increased headcount, M&A activity, clinical activity, outsourcing activities or need...